We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current VRDN market cap is 915.15M. The company's latest EPS is USD -3.7875 and P/E is -3.85.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.2M | 105k | 98k | 72k | 72k |
| Operating Income | -29.79M | -49.07M | -72.47M | -59.28M | -51.22M |
| Net Income | -28.91M | -45.79M | -68.15M | -55.06M | -47.66M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.46M | 1.05M | 2.96M | 1.77M | 314k |
| Operating Income | -41.98M | -110.38M | -79.73M | -134.3M | -254.45M |
| Net Income | -41.87M | -110.72M | -79.41M | -129.87M | -237.73M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 440.58M | 435.09M | 386.64M | 351.47M | 328.76M |
| Total Liabilities | 31.57M | 40.03M | 36.09M | 35.61M | 45.18M |
| Total Equity | 409.01M | 395.06M | 350.55M | 315.86M | 283.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.26M | 131.26M | 203.71M | 435.09M | 490.42M |
| Total Liabilities | 14.51M | 11.22M | 15.99M | 40.03M | 48.4M |
| Total Equity | 15.75M | -60.76M | 187.72M | 395.06M | 442.02M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -59.8M | -93.84M | -61.97M | -107.19M | -146.17M |
| Investing | 65.48M | -115.13M | -13.3M | 27.42M | 75.46M |
| Financing | 296.23M | 322.24M | 8.2M | 11.27M | 26.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -36.06M | -29.78M | -54.58M | -93.84M | -184.17M |
| Investing | 28.23M | -50.48M | -74.29M | -115.13M | -94.25M |
| Financing | 70k | 101.31M | 125.28M | 322.24M | 225.67M |
| Market Cap | 915.15M |
| Price to Earnings Ratio | -3.85 |
| Price to Sales Ratio | 2.92k |
| Price to Cash Ratio | 8.9 |
| Price to Book Ratio | 2.07 |
| Dividend Yield | - |
| Shares Outstanding | 62.77M |
| Average Volume (1 week) | 894.39k |
| Average Volume (1 Month) | 785.86k |
| 52 Week Change | -48.88% |
| 52 Week High | 28.99 |
| 52 Week Low | 10.925 |
| Spread (Intraday) | 1 (6.67%) |
| Company Name | Viridian Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.viridiantherapeutics.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
